Hematopoietic cell culture therapies (Part II): clinical aspects and applications
- 31 October 1996
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 14 (10) , 388-396
- https://doi.org/10.1016/0167-7799(96)10054-8
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (ROl HL 48276, GM08449)
- National Institutes of Health (ROl HL 48276, GM08449)
This publication has 44 references indexed in Scilit:
- CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34+ myeloma cellsBritish Journal of Haematology, 1996
- Cord Blood Stem Cells: How to Get Them and What to Do with ThemJournal of Hematotherapy, 1996
- Complete Updated ListingsHuman Gene Therapy, 1996
- High‐Dose Chemotherapy with Autologous Stem Cell Rescue for Breast Cancer: Yesterday, Today and TomorrowThe International Journal of Cell Cloning, 1996
- Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.The Journal of Experimental Medicine, 1996
- Umbilical cord blood transplantationTransfusion, 1995
- Maturation of Mobilized Peripheral Blood Progenitor Cells: Preclinical and Phase I Clinical StudiesJournal of Hematotherapy, 1995
- Quantitation, Mobilization, and Clinical Use of Long-Term Culture-Initiating Cells in Blood Cell AutograftsJournal of Hematotherapy, 1995
- Phenotypic Analysis and Characterization of CD34+ Cells from Normal Human Bone Marrow, Cord Blood, Peripheral Blood, and Mobilized Peripheral Blood from Patients Undergoing Autologous Stem Cell TransplantationClinical Immunology and Immunopathology, 1994
- Future Paradigm for Autologous Bone Marrow Transplantation: Tumor Purging andEx VivoProduction of Normal Stem and Progenitor CellsJournal of Hematotherapy, 1994